BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioMed X Launches EU Backed AI Precision Medicine Project With Barbados To Address Early Diabetic Kidney Disease

The new project, supported by the European Union’s PharmaNext Programme, focuses on population-specific molecular profiling and AI-driven precision m...

January 28, 2026 | News

Mabwell Doses First Patient In United States First In Human Trial Of Novel CDH17 Targeting ADC For Gastrointestinal Cancers

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed...

January 26, 2026 | News

Docquity Launches Engage To Bring Ai Powered Market Intelligence To HCP Engagement Across Asia

Docquity, a leading health tech company in Asia, announced the launch of Docquity EngageTM, an AI&nb...

January 16, 2026 | News

Immunofoco CAR T Therapy IMC002 Posts Strong Responses In Advanced Gastric And Gej Cancers At Asco Gi 2026

Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from ...

January 15, 2026 | News

Johnson And Johnson Amivantamab Combo Delivers 73% Response Rate In First Line Metastatic Colorectal Cancer

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable res...

January 12, 2026 | News

SN Bioscience Secures US FDA Orphan Drug Designation For SNB 101 In Gastric Cancer

SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (incl...

December 25, 2025 | News

AusperBio Reports 30% Functional Cure Rate With AHB 137 In Chronic Hepatitis B

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing oli...

December 16, 2025 | Report

JW Therapeutics Expands Strategic Collaboration with Regeneron to Advance TCR-T Cell Therapy and Platform Innovation

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunother...

November 03, 2025 | News

Olympus Launches OLYSENSE™ AI Endoscopy Portfolio in US and Europe

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today ann...

October 01, 2025 | News

Mabwell Secures FDA IND Clearance for CDH17-Targeting ADC 7MW4911 in Advanced GI Cancers

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D cod...

August 20, 2025 | News

Codex Genetics and Pacific Edge Partner to Introduce Cxbladder Genomic Urine Tests for Bladder Cancer Diagnosis in Hong Kong

Codex Genetics, one of the leading precision diagnostics companies in Hong Kong, announced an exclusive collaboration with Pacific Edge, the deve...

August 11, 2025 | News

Innovent Biologics Secures NMPA Approval for World’s First Dual GCG/GLP-1 Receptor Agonist Mazdutide for Weight Management in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

June 30, 2025 | News

Doer Bio Begins Phase 2 Trial of Tri-Agonist DR10624 for MASLD and MASH Treatment

Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...

April 24, 2025 | News

Brain Navi Initiates IPO Counseling with First Securities to Accelerate Growth in AI-Driven Surgical Robotics

Brain Navi Biotechnology Co., Ltd. ("Brain Navi") has officially begun IPO counseling with First Securities Inc., marking a strategic step toward acce...

April 18, 2025 | News

Stay Connected